Zoie Aiken

Dr Aiken has over 20 years of experience working in clinical microbiology and is based at Manchester Foundation Trust. Her specialist areas are in the management of infections in paediatric haematology and stem-cell transplant patients and critical care patients. She has a keen interest in education and oversees the training of Clinical Scientists locally as an STP Training Officer and nationally as Training and Education Lead for the LabMed Microbiology Professional Committee and Lead Assessor for the NSHCS end point assessments. She is also joint Head of Research and Development for the Manchester Medical Microbiology Partnership (MMMP) and Deputy Chair of the Paediatric Antimicrobial Guideline Development Group.

Pronouns:  She/her/hers

---

Wiebke Arlt

Wiebke Arlt is the Director of the MRC Laboratory of Medical Sciences (LMS), one of two intramural research institute of the UK Medical Research Council. The LMS is located on the Imperial Hammersmith Campus in London and is dedicated to the investigation of mechanisms underlying cardiometabolic disease and ageing, with a special focus on sex differences.

At the LMS, Wiebke leads a multi-disciplinary research group that investigates steroid metabolism and action in health and disease, with a focus on the sex-specific role of androgens in metabolic dysfunction. Wiebke is also an honorary consultant endocrinologist at Imperial College Healthcare NHS Trust with a special interest in adrenal and reproductive disorders.

Wiebke's scientific work has attracted major national and international prizes. She was elected Fellow of the UK Academy of Medical Sciences in 2010.

Pronouns:  She/her/hers

---

Nick Armfield

Nick Armfield MSc MIBMS is a senior biomedical scientist at The Walton Centre for Neurology and Neurosurgery. Nick gained a BSc (Hons) at Liverpool John Moores University and qualified at Salford Royal biochemistry. Following a specialist role at Liverpool Clinical Laboratories, a MSc at University of Chester and over a decade’s experience in NHS laboratories, Nick is now a specialist in neuroimmunology and neurobiochemistry. The Walton Centre Neuroimmunology lab offers incite into neuroinflammation by offering the classical tests oligoclonal bands by isoelectric focussing and CSF index. With the emergence of CSF κ Free Light Chain as a marker of intrathecal inflammation, Nick’s recent work has explored the benefits of alternative laboratory markers of intrathecal inflammation. Other professional activities include published and presented works for therapeutic monitoring of ketamine and metabolites.

Prounouns:  He/him/his

---

Rue Ball

Rue graduated as a Clinical Scientist in 2021. She has worked in routine biochemistry at Synnovis for three years, and during that time she has done audits, research and teaching to improve the care medical laboratories provide to trans & non-binary people. She is co-chief investigator of a forthcoming nationwide study about PSA reference intervals in trans women and non-binary people with a prostate.

Pronouns:  She/they

---

Roberto Bellanti

Dr Roberto Bellanti is an MRC Clinical Research Fellow and an honorary neurology registrar at Oxford and University College London Hospitals. He is currently completing his doctoral training, supervised by Professor Simon Rinaldi and Professor Mike Lunn. His research focuses on neuroinflammation and biomarker discovery. He develops peripheral nerve specific biomarker assays using ultrasensitive technologies and stem cell-based models of immune-mediated nerve injury.

---

Ann Bowron

Ann is based in the Metabolic and Newborn Screening laboratory at Newcastle upon Tyne Hospitals. She has a long-standing interest in inherited metabolic diseases and participates in the Stakeholder Group of the UK Metabolic Biochemistry Network (MetBioNet).  She has helped to organise this session on behalf of MetBioNet.

Pronouns: She/her

---

Charlotte Brookfield

I work across all the acute adult hospitals in Liverpool with a particular specialist interest in mycobacterial and vascular infections. I am laboratory lead for the microbiology department at Liverpool Clinical Laboratories and have a passion for diagnostic stewardship.

Pronouns: She/Her

---

Greg Bulmer

I am currently a 3^rd year Trainee Clinical Scientist in Biochemistry at University Hospitals Birmingham NHS Foundation Trust. A research background in carbohydrate and organic volatile chemistry led me to an interest in various hyphenated mass spectrometry techniques.   My current interests include the clinical application of LC-MS/MS in the development of non-invasive tests for at-home or paediatric populations, such as salivary steroid quantification.

Pronouns: He/him

---

Carrie Chadwick

Carrie completed her Clinical Scientist Training at South Manchester University Hospital Trust and Royal Liverpool University Hospital.   She was appointed as a Principal Clinical Scientist at Aintree University Hospital and also at The Walton Centre NHS Foundation Trust in 2008, where she specialised in Neurobiochemistry and Neuroimmunology. Carrie was appointed as Consultant Clinical Scientist and Clinical Director at The Neuroscience Laboratories at The Walton Centre NHS Foundation Trust in 2013.

Carrie has a specialist interest in paraneoplastic antibodies, neurodegeneration, neuroinflammation, therapeutic drug monitoring and biobanking; she established a cerebrospinal fluid and blood bio bank at the Trust in 2016, which has since been renamed The Liverpool Neuroscience Biobank at The Walton Centre (LNBW). The LNBW has enabled collaborative translational research with local health partners.  Carrie is also the current LabMed Chair for the North-West region.

Pronouns:  She/her

---

Kamaljit Chatha

Dr Kamaljit Chatha is a Consultant Clinical Biochemist, Clinical Lead for Biochemistry and Immunology and Director of the Bowel Cancer Screening Midlands and North West Hub at the University Hospitals Coventry and Warwickshire (UHCW).  Kamaljit has a keen interest in research and development and has several publications that covers the novel and innovative use of biomarkers to detect chronic disease such as cardiovascular disease and renal disease.  She also has an interest in screening, as highlighted by her work in Bowel Cancer Screening, and combine FIT with artificial intelligence systems to improve bowel cancer detection in the screening programme.  Kamaljit has been actively involved with regional and national Association for Laboratory Medicine (ALM) committees and is currently Director of Publications and Communications for the ALM, promoting the profession and the excellent work it delivers.  Kamaljit is also an Honorary Clinical Lecturer for the University of Warwick and is part of the Institute of Cardiometabolic Medicine (ICMM) at UHCW.

Prounouns:  She/her

---

Heather Church

Heather studied Biology and Chemistry at Goldsmith’s College, University of London, graduating in 1987. She then gained a Ph.D. in analytical chemistry from the Department of Chemistry, University of Manchester in 1991. Heather worked as a post-doctoral research scientist within the Department of Obstetrics and Gynaecology, University of Manchester from 1991-1999 with a specific interest in cell adhesion and the role of extracellular matrix in human physiology.

In 1999 Heather took up the position of Clinical Biochemist in the Willink Biochemical Genetics Unit, now part of the Genomic Medicine, Manchester Foundation Trust with a specialist interest in lysosomal disease. Heather was appointed Principal Clinical Scientist in 2008 and has overseen the introduction of highly specialised laboratory services focussing on the improved diagnosis and monitoring treatment efficacy of pioneering new treatments for patients with lysosomal disease.

---

Maria Concepción Masip

With over 35 years of experience, María Concepción Masip has excelled in the fields of clinical biochemistry and medicine. A Doctor of Medicine and Surgery from the University of La Laguna, she specialized in clinical biochemistry at the University Hospital of Canarias, where she became Head of Section in the Biochemistry Department, leading key research on metabolic disorders. Over the years, she has combined clinical practice with teaching, supervising residents, and contributing extensively to scientific literature. Her most recent work, an article on traumatic brain injuries, explores the metabolic effects of these injuries. Her passion for knowledge led her to earn a second Ph.D. in Art History, firmly believing that medicine and art go hand in hand. “A doctor who knows only medicine knows nothing of medicine”—a philosophy that has shaped her entire career.

---

David Dorwood

I am a pathologist working in Edinburgh with a particular interest in pulmonary inflammation in response to infection and malignancy.  Having undertaken a PhD investigating neutrophil responses to acute lung injury at the University of Edinburgh I completed pathology training in 2020.  During the first wave of the COVID-19 pandemic I co-lead the ICECAP post mortem study describing the pathological changes seen in fatal COVID-19.  Currently, I am lead thoracic and hospital autopsy pathologist in NHS Lothian.

Pronouns:  He/him

---

Allan Dunlop

I am a Consultant Clinical Scientist within the Department of Clinical Biochemistry, Queen Elizabeth University Hospital (NHS Greater Glasgow & Clyde).

I began my Clinical Scientist training at Aberdeen Royal Infirmary (NHS Grampian) in 2010, moving to Glasgow in 2013. My current areas of interest include Core Biochemistry and automation, Toxicology and therapeutic drug monitoring.

Pronouns: He/him/his

---

Fadoua El Hiayadi

Fadoua El Hiayadi is a Specialist Biomedical Scientist with extensive experience in multidisciplinary laboratory sciences, including transfusion, haematology, coagulation, and immunology. She has worked in renowned institutions such as Carlos Haya Hospital in Malaga, Spain (2012-2013), and South Hants Hospital (2015-2016), where she worked as a phlebotomist. Currently, she contributes her expertise as a team leader at Southampton General Hospital, focusing on performing advanced laboratory diagnostics and providing clinical support.

With a strong academic foundation and years of hands-on experience, Fadoua is committed to advancing healthcare through innovation and excellence in diagnostics.

---

Danielle Freedman

Consultant Chemical Pathologist, Associate Physician in Endocrinology, Clinical Director of Pathology, and Deputy Medical Director of Bedfordshire Hospitals (cross site).  Lead CMO for ME5 Pathology Network.

Trained in medicine at the Royal Free Hospital School of Medicine, University of London, and then further training in Clinical Biochemistry and Endocrinology at the RFHSM and the Middlesex Hospital, University of London.

Nationally, elected Vice President of Royal College of Pathologists (RCPath) (2008 - 2011)  

National member of the Association for Clinical Biochemistry and Laboratory Medicine (ACB) Council 2011 - 2015.  Currently, UK member of the (EFLM) Working Group on Post Analytic Phases (2018 - 2023)

 Chair of Lab Tests Online Board UK (2012 - ) A Peer reviewed, Non Commercial, Patient Centered website

Main interests include clinical endocrinology, point of care testing and, importantly, the value of laboratory testing with regard to patient safety and patient outcome.

 Over 100 publications in peer review journals including Lancet, New England Journal of Medicine, JAMA and Annals of Clinical Biochemistry and 10 book chapters.

Nominated as one of the TOP 100 International Power List of Influential Laboratory Medicine Professionals (November 2015)

In 2018, awarded the very prestigious award of Honorary Membership of the ACB for her International work in Laboratory Medicine.

Pronouns:  She/her/hers

---

Maki Furuya

Maki Furuya is a clinical laboratory technician at Musashino Red Cross Hospital in Tokyo, where she specializes in biochemistry within the clinical laboratory department. In addition to her laboratory duties, she actively contributes to hepatitis awareness initiatives. She is also dedicated to supporting the care of diabetes patients, using her expertise to engage in collaborative, multidisciplinary efforts.

---

Naomi Gadsby

Naomi Gadsby has a PhD from the University of Edinburgh and completed her pre- and post-registration clinical scientist training in Medical Microbiology in NHS Lothian. She became a Fellow of the Royal College of Pathologists by examination in Medical Microbiology in 2017. Since 2019 she has been working as a Consultant Clinical Scientist in Medical Microbiology at the Royal Infirmary of Edinburgh.

---

Rouvick Gama

Dr Rouvick Gama is a clinical research fellow and specialist renal registrar with an interest in clinical research. His field of research is assessing and addressing ethnic disparities in kidney disease, with an aim of improving chronic kidney disease (CKD) diagnosis and management and reducing health inequalities.  He has previously published an observational study which highlighted the inaccuracy of using the ethnicity co-efficient for people of Black ethnicity in a UK population, contributing to the removal of ethnicity coefficients in the NICE 2021 CKD guidelines.

He is currently undertaking a PhD, funded by Kidney Research UK, which aim to explore the impact of kidney function assessment (eGFR) on people of all ages and from diverse backgrounds. In addition, his work includes using novel point-of-care technologies to improve early identification and management for people with CKD, through the development of new clinical pathways. His works aims to improve the accuracy of kidney function measurement and management of CKD whilst reducing ethnicity-related and health inequalities, thereby addressing a growing public health concern. 

Pronouns: He/him

---

Ian Godber

Ian trained in Clinical Biochemistry in Dundee and Nottingham, then moved to NHS Lanarkshire initially as a Principal Biochemist, and was later appointed to a post as Consultant Clinical Scientist and Clinical Lead, where he developed an interest in laboratory processes and IT. He was the Clinical Lead for the Scottish Clinical Biochemistry Managed Diagnostic Network from 2016-2020. He moved into his current role as Consultant Clinical Scientist and Lead Clinician in Biochemistry at the QEUH in Glasgow in 2020.

Ian currently chairs the Specialist Advisory Committee for Clinical Biochemistry within the Royal College of Pathologists and after sitting on many committees of the Association for Laboratory Medicine, he was appointed as President Elect in 2024 and will take up the Presidency at LabMedUk in Manchester later this year.

Pronouns:  He/him/his

---

Pilar Gonzalez Romero

Pilar María González Romero is a specialist in Family and Community Medicine with 20 years of experience in the Emergency Department at Hospital Universitario Nuestra Señora de la Candelaria, where she serves as Clinical Unit Head, focusing on training and innovation. She earned her PhD Cum Laude in 2016. A professor at the University of La Laguna since 2019, she holds master’s degrees and expert certifications in emergency medicine, critical care, and clinical management. She has published scientific articles and book chapters, with her latest article focusing on the use of biomarkers in the management of mild traumatic brain injury. Passionate about medicine, she strives to enhance patient care through knowledge and continuous improvement.

---

Nicole Gossan

I am a Principal Clinical Scientist in Genomics, working in rare disease at the Manchester Genomic Laboratory Hub (NWGLH). I am the lead for the Metabolic genetics service within the lab. I have previously worked in NHS Genomics laboratories in Nottingham and Liverpool.

Prounouns:  Dr/she/her

---

Zachary Green

Zachary Green is a clinical research fellow working at the University Hospital Southampton and University of Southampton. His background is in paediatric gastroenterology and specific research interest is in inflammatory bowel disease (IBD) in young people. In his CICRA (Crohn’s and Colitis in Childhood Research Association) funded fellowship he is using large datasets, including clinical biomarkers and unstructured medical reports to identify different groups of patients within the IBD umbrella, which can in turn be used to personalise care and predict outcomes.  

Pronouns:  He/him

---

Dominic Haigh

Dominic is a medical doctor who trained in Clinical Virology and Infectious Diseases in Manchester.  He works Manchester Medical Microbiology Partnership for the NHS and the UK Health Security Agency. He teaches and examines for the University of Manchester. Dominic enjoys interesting cases and education, and has been involved in research, audit and Quality Improvement work regarding Covid, mpox, High-Consequence Infectious Diseases and other infections.

Pronouns: He/ him

---

Sally Hanton

Sally is a Principal Clinical Scientist in Neurobiochemistry and Neuroimmunology, working in the Neuroscience Laboratories at The Walton Centre NHS Foundation Trust in Liverpool. On completion of her BSc in Biochemistry, Sally undertook a PhD and several years of postdoctoral work researching intracellular protein transport. She then went on to train as a clinical scientist in Liverpool, and has worked in her current role since 2016.

Sally’s interests include therapeutic drug monitoring and measurement of neurologically relevant metabolites using UPLC-MS/MS, as well as the development of methods to detect potential novel autoantibodies.

Pronouns: she/her

---

Sharman Harris

Sharman is a Consultant Clinical Scientist and Clinical POCT Lead at the Stockport NHS Foundation Trust. She is also Clinical Chair of the Greater Manchester POCT Subgroup contributing towards developing the POCT strategy for the network and a member of the North West POCT group.

Sharman  worked at Betsi Cadwaladr University Health Board in North Wales, before joining the team at Stepping Hill Hospital in March 2021. Prior to this Sharman worked in the North West Region at the Royal Manchester Children’s Hospital  Willink Unit (specialising in Mitochondrial DNA testing) after completing training at Hope Hospital in Salford.

Sharman was Chair of the then ACB (Association of Clinical Biochemistry and Laboratory Medicine) Wales region from 2019 to 2021 and was previously Secretary of the region from 2015. She was also Chair of the All Wales Clinical Biochemistry audit group and North Wales Clinical Biochemist audit lead.

Her main interests include Point of Care testing (POCT), in particular the development of POCT services closer to home and supporting antimicrobial stewardship.  Her FRCPath dissertation involved development of a rural community POCT service. Recently she has been involved in setting up the North West and Greater Manchester Acute Respiratory Infection hub POCT pilot and POCT Pathology network group evaluation of genetic POCT with the Genedrive analyser.

Sharman has also maintained a keen interest in R&D throughout her career, initially in endocrinology at Hope Hospital in Salford. She represented Pathology on the Health Board Research and innovation committee, being Principal Investigator on a number of studies including for Covid-19 testing. Currently she is Pathology R&I lead at Stockport FT.

Pronouns:  She/her/hers

---

Melanie Hart

Dr Melanie Hart is a Consultant Clinical Scientist and Laboratory Director of the Neuroimmunology and CSF Laboratory (NICL) at the National Hospital for Neurology in London (UCLH) with a honorary research contract with University College London and a Fellow of the Royal College of Pathologists. As Laboratory Director she oversees a comprehensive repertoire of diagnostic NHS neurological tests the specialist centre provides to hospitals across the UK from dementia markers to autoimmune neurology tests. She is supported by the NIHR UCL Biomedical Research Centre and is a collaborator on current grants including the Blood Biomarker Challenge for Alzheimer’s Disease (ADAPT) Trial and Translation Accelerator Grant for diagnostic alpha synuclein biofluid measurement in Parkinson’s disease, working to translate these tests into clinical use in NICL. She is a committee member of the Specialist Advisory Group for Neuroimmunology at UK NEQAS and a member of the Association for British Neurologists, British Society for Immunology and Association of Laboratory Medicine.

---

Katharine Hayden

Kath Hayden is a Consultant Clinical Biochemist at Manchester University NHS Foundation Trust and Honorary Senior Lecturer at the University of Manchester.

Following training in South Manchester, Kath has held posts in hospitals in Manchester and Liverpool over a 35 year period, overseeing significant advances in analytical technologies, point of care testing (POCT) and harmonisation of laboratories. With specialist interests in endocrinology, POCT, leadership and service improvement, her latest roles have been as Clinical Head of Division for Laboratory Medicine at Manchester University NHS Foundation Trust, Trust Lead Healthcare Scientist, Clinical Director for Laboratory Medicine and Head of Service for Clinical Biochemistry at Central Manchester University Hospitals NHS Foundation Trust.  

Pronouns: She/her

---

Nuthar Jassam

Nuthar is a Consultant Clinical Biochemist and Head of Biochemistry Department at Harrogate and District NHS Foundation Trust and a Clinical Director of Blood Sciences  Departments for a network of three laboratories; Harrogate, Airedale and Bradford.

Nuthar takes pride in the fact that she enjoys research in any area of Clinical Biochemistry. She published over 45 papers and article reviews and over 22 abstract and conference papers. She is known for her interest in harmonisation of postgraduate training across Europe and standardisation of pathology practices within clinical networks. She brings experience in the field of quality of laboratory medicine by being member of a number of Experts on Laboratory Quality working groups and an invited speaker on national and international platforms in this field.

Nuthar has been a member/chair of a number of working groups and committees within the Association of Clinical Biochemistry and Laboratory Medicine in the UK. She currently chairs the European Federation of Laboratory Medicine (EFLM) Register. Nuthar previously chaired the EFLM working group for the post- graduate syllabus for European laboratory medicine specialists and was a board member of the European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4).

Pronouns:  She/her

---

Helen Jopling

Helen completed her Biochemistry degree and PhD at the University of Leeds with a year spent studying in Paris. Her clinically focussed PhD led to training as a clinical scientist at Manchester Royal Infirmary, before taking up a substantive post at Royal Manchester Children’s Hospital. Helen started guest lecturing on the MSc programme provided at the University of Manchester to accompany STP training, and this led to taking on a permanent contract. Helen is Director of Education in the school of medical sciences, leading the provision of degree programmes at both undergraduate and postgraduate level. Alongside this Helen maintains a teaching and research portfolio in Clinical Biochemistry and Medical Education, and has a role as an associate editor for the Annals of Clinical Biochemistry.

 

---

Tejas Kelaria

Dr Tejas Kalaria is a Consultant in Chemical Pathology and Metabolic Medicine at Black Country Pathology Services, The Royal Wolverhampton NHS Trust, and Member Young Scientist on the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) post-analytical phase working group. Dr Kalaria’s areas of interest include endocrine biochemistry and post-analytics.

Pronouns:  He/him/his

---

Katy Keymer

After completing Grade A training in immunology at the Protein Reference Unit in Sheffield and becoming registered as both a BMS and a clinical scientist, I spent a short time in Haematology at the Royal Preston Hospital. I then moved to the University on Manchester as a teaching focussed lecturer where I co-led the academic component of the immunology STP. During this time, I fulfilled an honorary contact with the immunology department in Preston, allowing me to maintain my registration and a practicing clinical scientist. I later returned to full time clinical practice as the sole clinical scientist at Liverpool Clinical Laboratories, where I have been for the last 8 years.

Pronouns: She/her 

---

Eric Kilpatrick

Professor Eric Kilpatrick is a Consultant in Chemical Pathology at Wythenshawe Hospital in Manchester. He is also an Honorary Professor of Clinical Biochemistry at Hull York Medical School and was Professor of Pathology and Laboratory Medicine at Weill Cornell Medicine, Cornell University. He has previously been Division Chief for Clinical Biochemistry at Sidra Medicine in Doha, Qatar, and a Consultant in Chemical Pathology at both Manchester Royal Infirmary and Hull Royal Infirmary. He is a past President of the Association for Clinical Biochemistry and Laboratory Medicine (ACB) and previous Chair of the Science Committee of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). He has a long-standing research interest in laboratory medicine and diabetes and has published over 200 papers on these and other topics.

---

Thomas Lamb

Thomas Lamb is an infectious diseases consultant working at North Manchester General Hospital. Thomas has taken time out of his medical training to work in India, Bangladesh and Myanmar. During this time he has developed an interest in Toxicology and snakebite. Following his return to the UK, he has completed registrar training in Infection medicine before obtain a CCT in Medical microbiology and infectious diseases in 2024.

---

Phillip Monaghan

After graduating from the University of Manchester Institute of Science and Technology (UMIST) in Biochemistry with Applied Molecular Biology, Phillip went on to complete a PhD in Molecular Enzymology at the University of Leicester.  He subsequently commenced training in Clinical Biochemistry at Wirral University Teaching Hospital, Alder Hey Hospital and University Hospital of South Manchester.  Phillip has been a Clinical Scientist at The Christie NHS Foundation Trust and more recently The Christie Pathology Partnership in Manchester, UK, for the past 15 years, and is Clincal Director of Pathology.  Phillip is Honorary Lecturer at the University of Manchester, Cancer Sciences Division within the School of Medical Sciences, previously lecturing on the MSc Clinical Sciences programme and the Advanced Therapeutics Medicinal Products programme.  Phillip is a member of the UK NEQAS Steering Committee for Immunochemistry, and previous Chair of the NQAAP for Chemical Pathology (Chair: 2019-2022).  Phillip is Chair of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Test Evaluation (WG-TE) and is Editor-in-Chief for the Annals of Clinical Biochemistry. 

Special research interests include evidence-based laboratory medicine (test evaluation), biochemical endocrinology, and translational biomarker development. Phillip is Co-Investigator on the VALTIVE clinical trials programme for the validation of a novel vascular response biomarker to guide VEGFi therapy in ovarian cancer.  Phillip was awarded the Silver Research Medal from the Royal College of Pathologists in 2012 for his work on serum cortisol measurement in Cushing’s syndrome. 

---

Elaine Murphy

Elaine Murphy qualified from Trinity College, Dublin.  She trained in chemical pathology / metabolic medicine at Imperial College NHS Trust, London and developed a specialist interest in inherited metabolic disease.  She has worked as a consultant at the Charles Dent Metabolic Unit, based at the National Hospital for Neurology and Neurosurgery, Queen Square since 2008.  The unit manages over 1900 adults with rare inherited disorders of metabolism.  Staff at the unit specialize in the dietary management of specific inherited disorders of metabolism – including the aminoacidopathies, fatty acid oxidation defects, urea cycle disorders, glycogen storage disorders, disorders of carbohydrate metabolism, and other rare disorders of bile acid and cholesterol metabolism.  It is also an NHS England specialized service for the management of patients with lysosomal storage disorders. 

Pronouns:  She/her

---

Virginia Newcombe

Virginia Newcombe is an Associate Professor in Emergency Medicine, Cambridge University, as well as an Honorary Consultant in Neurosciences and Trauma Critical Care, and Emergency Medicine at Addenbrooke's Hospital. She holds the Royal College of Emergency Medicine Professorship and an NIHR Rosetrees Trust Advanced Fellowship. Virginia's research focuses on traumatic brain injury (TBI) of all severities using biomarkers and advanced neuroimaging with a particular interested in how the acute phase affects long-term outcome trajectories. She is Chief Investigator for BRAINS-TBI and POCkET, multi-center studies investigating use of blood biomarkers in emergency departments for diagnosis and prognosis of mild TBI. 

Pronouns: She/her 

---

Karen Perkins

A diverse career to date, which includes post-doctoral research associate at National Heart and Lung Institute, London, team leader at Unilever R&D working on a project focused on what it takes to be a healthy octogenarian – living healthy for longer. I am currently Principal Clinical Scientist at Morecambe Bay Hospitals NHS Trust, since 2020. I have a special interest in capillary sampling and enabling access to blood tests for underserved populations.

Pronouns:  She/her

---

Kate Phillips

Catherine (Kate) is a Clinical Scientist and is on the Higher Specialist Scientist Training programme in Clinical Virology. She currently works with the Manchester Microbiology Partnership for both NHS and UKHSA. She has previously worked in Microbiology as a Senior Biomedical Scientist. Catherine has interest in Hepatitis C, DNA viruses, and the application of next-generation sequencing and bioinformatics in viral research.

Pronouns:  She/her

---

Mario Plebani

No bio provided

---

Monika Radike

Dr Monika Radike MD, PhD, FRCR is a Consultant Cardiothoracic Radiologist practicing at Liverpool Heart and Chest Hospital NHS Foundation Trust, UK. While working as a clinical radiologist, she has also been involved in various research projects, presentations and publications in her field. Dr Radike actively participates in medical education, training and mentoring radiologists, and has established a radiology fellowship programme at Liverpool Heart and Chest Hospital. 

Pronouns: She/her

---

Tricia Ravalico

Tricia Ravalico is founder and executive lead of the UNIVANTS of Healthcare Excellence Program, a prestigious global award program that was developed to recognize, amplify and inspire best practices in healthcare transformation.  She also leads Global Scientific Leadership at Abbott with responsibilities that include cultivation of scientific partnerships, collaborations, and the development of global education strategies across congresses and healthcare disciplines. 

Tricia serves on the Executive Board of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), is also a liaison to the IFCC Task Force for Corporate Members where she has also served as chair for 4 years.  She was formerly a board member of the IFCC Publications and Communications Division for 6 years, and has actively supported multiple IFCC programs for over a decade including the IFCC Committee for the Clinical Application of Cardiac Bio-Markers (CCB).

Over the course of her 28-year career in core diagnostics, she has held multiple leadership positions in Research and Development, Scientific Affairs, Medical Affairs, Global Marketing and Education.

 

---

Riina Richardson

Dr Richardson is the Clinical Head of Service for the Mycology Reference Centre Manchester and member of the MFT Infectious Diseases team. She is an internationally recognised expert, senior researcher, educator and clinician.  She has published over 180 peer-reviewed articles and book chapters in medical microbiology, mucosal immunology and infectious diseases, h-index is 51.

She has special expertise in the management of a spectrum of mycoses including chronic superficial candidiasis, candidaemia and other fungal infections in immunocompromised, as well as in antimicrobial stewardship and infection prevention. She is an author of the BASHH guideline on vulvovaginal candidiasis as well as the ECMM/ISHAM Candidiasis and Rare yeasts guidelines. She is the Lead for Infectious Diseases learning for University of Manchester Medical School, the Chair of the UK SMI Bacteriology Working Group, an ESCMID Educational Officer and lead for the eAcademy, and an Editor for Journal for Antimicrobial Chemotherapy.

Pronouns:  She/her

---

Fiona Riddoch

Fiona trained as a Clinical Scientist in Biochemistry. Currently employed as a Consultant Clinical Scientist for POCT in Berkshire and Surrey Pathology Services (BSPS); the service covers 5 acute NHS Trusts, and multiple community services. Over the last 5 years she has developed multidisciplinary clinical and technical expertise needed for POCT, and in particular focussing on IT, risk management and analytical & clinical verification of POCT analysers, using these skills to support the BSPS POCT team in achieving accreditation against ISO:15189(2022) for our multi-site blood gas analyser service. She has led the BSPS POCT team on national verification projects, including multiple SARS-CoV-2 and winter multiplex methods on behalf of NHS England, being an exemplary verification and implementation site for POCT in Hospital@Home services; working to provide evidence that can be used nationally to support implementation of POCT CRP and high-sensitivity troponin. She has won national awards for quality improvement projects and clinical audit, by demonstrating clinical impact and patient benefit of pathology services.

---

Vincent Sapin

Vincent Sapin is a clinical biologist and the head of the Biochemistry and Molecular Genetics Department at the University Hospital of Clermont-Ferrand. He is Professor of Biochemistry and Molecular Biology at the School of Medicine (Université Clermont Auvergne). He is head of the research team "Translational approaches of epithelial injury and repair" at the Institut "Genetic, Reproduction and Development". His research focuses on the development of pathophysiology and biomarkers related to mild traumatic brain injury, premature rupture of membranes and acute respiratory distress syndrome.

---

Emma Stevenson

Emma is a principal clinical scientist based in the clinical biochemistry laboratories at Gloucestershire Hospitals NHS Foundation Trust. She is Chair of the LabMed Education Group and Deputy Director of Education, Training and Workforce. Outside of education and training, Emma’s main interest in the laboratory is quality, including EQA, IQC and measurement uncertainty. Emma is a member of the RCPath’s Chemical Pathology National Quality Assurance Panel, which oversees the running of EQA schemes in biochemistry.

Pronouns:  She/her

---

Nobuharu Tamaki

Dr. Nobuharu Tamaki is the Associate Director of Gastroenterology and Hepatology at Musashino Red Cross Hospital in Tokyo, Japan. With over 20 years of experience as a physician, he earned his Ph.D. from the Graduate School of Medicine at Yamanashi University. Dr. Nobuharu Tamaki specializes in the treatment of hepatitis and hepatocellular carcinoma and conducts clinical research focusing on viral hepatitis, steatotic liver disease, and hepatocellular carcinoma. He has published more than 150 papers to date, including in prestigious journals.

---

Vicki Thurston

I started my training in 2009 and was a trainee in Nottingham and Derby. I have been working in Nottingham as a Senior Clinical Scientist since 2012 and am involved in the busy Immunochemistry section where we perform serum electrophoresis, immunofixation, serum free light chains, ALP isoenzymes and Lipoprotein electrophoresis.

---

Nathan Timbrell

Nathan is a Senior Biomedical Scientist working within Synnovis, St Thomas' Hospital in London. He began his career on the Practitioner Training Programme (PTP) and trained at Royal Devon and Exeter Hospital. He later worked within Clinical Biochemistry at both Royal United Hospitals Bath and North Bristol NHS Trust, gaining experience in specialist sections such as Newborn Screening, Biochemical Genetics, and Clinical Toxicology. This gave Nathan exposure to several different chromatography and mass spectrometry methods. Now, he utilises this expertise within the Human Nutristasis Unit, a laboratory that specialises in the static and functional markers of vitamin status, along with testing related to warfarins and superwarfarins.

Nathan is currently undertaking equivalence training to register as a Clinical Scientist. As part of this, he has recently completed both an MSc in Biomedical Science and passed the IBMS Higher Specialist Diploma in Clinical Chemistry. These qualifications led Nathan to join the IBMS Specialist Advisory Panel in Clinical Biochemistry, where he is able to advise on science and policy. Nathan's interests also led him to become the deputy manager of the KEQAS external quality assurance scheme for  Protein induced by vitamin K absence-II (PIVKA-II).

Pronouns: He/him/his

---

Philip Turner

Dr Phil Turner is a senior researcher in the Infections, Respiratory and Acute care Research Group and the Director of Operations of the NIHR HealthTech Research Centre in Community Healthcare based at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. His research interests include the diagnosis and management of common infections and approaches to antimicrobial stewardship in community healthcare settings. Recent activities include co-leadership of the RAPTOR-C19 evaluations of point-of-care tests for SARS-CoV-2 and other respiratory viruses in community care, trial management support for the trans-European VALUE-Dx PRUDENCE RCT of the clinical and cost-effectiveness of diagnostic interventions for RTI, and co-investigation on the NIHR and NHSE-funded TOUCAN evaluation of novel diagnostics for acute uncomplicated UTI.

Pronouns:  He/him/his

---

Ed Wilkes

Ed completed his PhD and post-doctoral work at Barts Cancer Institute, where he developed computational methods for predicting drug response to small kinase inhibitors in cancer models. He went on to train as a clinical scientist in the NHS and is now the Head of Research at Kinomica. His interests primarily lie in predictive modelling, statistics education, systems biology, and (phospho-)proteomics.

Pronouns: He/him/his

---

Alexandra Yates

Alexandra, is a  Consultant Clinical scientist in the Clinical biochemistry department at the Countess of Chester hospital, GB, where her interest include analytical interferences, renal medicine, and quality improvement. Other wider interest include equality and diversity within  healthcare organizations, Alexandra is passionate in  enacting meaningful change leading to equity for all and recognizing the benefits this bring  to the healthcare and wider community.

Alexandra was appointed as Director of Scientific affairs for the Association for clinical biochemistry and Laboratory medicine in May 2019 after 5 years on the scientific committee, and a previous role   as a national member on the ACB council.

As chair of the Scientific and clinical practice committee, she leads  the committee in the vision  that; the scientific committee  and clinical practice committee should serve all LabMed members across pan-pathology disciplines,  enabling and promoting  translation  research and innovation,  and providing  scientific and clinical expertise to  our strategic partners, benefiting the  wider health care  community.

Pronouns:  She/her

---